ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,687 | -27.1% | 5,627 | 0.0% | 0.00% | -40.0% |
Q2 2023 | $20,145 | +64.2% | 5,627 | 0.0% | 0.01% | +66.7% |
Q1 2023 | $12,267 | -81.9% | 5,627 | 0.0% | 0.00% | -82.4% |
Q4 2022 | $67,693 | +88.0% | 5,627 | 0.0% | 0.02% | +70.0% |
Q3 2022 | $36,000 | +38.5% | 5,627 | 0.0% | 0.01% | +42.9% |
Q2 2022 | $26,000 | -46.9% | 5,627 | 0.0% | 0.01% | -36.4% |
Q1 2022 | $49,000 | -38.8% | 5,627 | 0.0% | 0.01% | -31.2% |
Q4 2021 | $80,000 | -35.5% | 5,627 | 0.0% | 0.02% | -40.7% |
Q3 2021 | $124,000 | +65.3% | 5,627 | 0.0% | 0.03% | +68.8% |
Q2 2021 | $75,000 | +31.6% | 5,627 | 0.0% | 0.02% | +23.1% |
Q1 2021 | $57,000 | +137.5% | 5,627 | 0.0% | 0.01% | +116.7% |
Q4 2020 | $24,000 | +60.0% | 5,627 | 0.0% | 0.01% | +20.0% |
Q3 2020 | $15,000 | -25.0% | 5,627 | 0.0% | 0.01% | -28.6% |
Q2 2020 | $20,000 | +17.6% | 5,627 | 0.0% | 0.01% | -22.2% |
Q1 2020 | $17,000 | -41.4% | 5,627 | 0.0% | 0.01% | -35.7% |
Q4 2019 | $29,000 | +61.1% | 5,627 | 0.0% | 0.01% | +40.0% |
Q3 2019 | $18,000 | – | 5,627 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |